miRNA signature associated with outcome of gastric cancer patients following chemotherapy
<p>Abstract</p> <p>Background</p> <p>Identification of patients who likely will or will not benefit from cytotoxic chemotherapy through the use of biomarkers could greatly improve clinical management by better defining appropriate treatment options for patients. microRN...
Main Authors: | Kim Chang, Kim Hark K, Rettig R Luke, Kim Joseph, Lee Eunbyul T, Aprelikova Olga, Choi Il J, Munroe David J, Green Jeffrey E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Medical Genomics |
Online Access: | http://www.biomedcentral.com/1755-8794/4/79 |
Similar Items
-
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection <it>versus </it>histologic macrodissection
by: Choi Il, et al.
Published: (2011-06-01) -
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
by: Hark Kyun Kim, et al.
Published: (2011-02-01) -
Signature miRNAs in peripheral blood monocytes of patients with gastric or breast cancers
by: Le Shu, et al.
Published: (2018-10-01) -
Impact of cellular miRNAs on circulating miRNA biomarker signatures.
by: Radha Duttagupta, et al.
Published: (2011-01-01) -
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
by: Babak Otoukesh, et al.
Published: (2020-06-01)